Streetbeat News

Stock Prices

UG

United-Guardian, Inc. (NASDAQ:UG) shares rose by 5.28% to $8.26 after announcing a significant dividend increase to $0.25 per share, payable on February 20, 2024. This marks the 29th consecutive year of dividend payments, with the increase supported by expanded marketing activities and a strategic focus on growth. Despite a 7% rise in the last six months, UG underperformed the S&P 500.

Portfolio Pulse from Nabaparna Bhattacharya

February 02, 2024 | 4:12 pm

HUT

MARA

Marathon Digital Holdings, Inc. (MARA) and Hut 8 Corp. (HUT) announced the termination of property management agreements at two of Marathon's Bitcoin mining sites. Hut 8 will receive a termination fee of $13.568 million and continue to provide services until April 30. Marathon aims to leverage its operational expertise at new sites in Texas and Nebraska.

Portfolio Pulse from Erica Kollmann

February 02, 2024 | 4:11 pm

AMZN

Amazon.com Inc (NASDAQ:AMZN) reported strong Q4 results with 14% year-on-year sales growth and 51% EBITDA growth, leading to multiple analysts raising their price targets. The company's focus on GenAI apps, fulfillment efficiencies, advertising, and AWS services were key drivers. Operating margins expanded, and Amazon provided better-than-anticipated guidance for Q1. Shares rose by 7.08% to $170.56.

Portfolio Pulse from Priya Nigam

February 02, 2024 | 4:10 pm

PIPR

Piper Sandler's stock is trading higher following the announcement of their Q4 results, which surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 4:08 pm

REGN

SNY

TSVT

Regeneron Pharmaceuticals Inc (REGN) reported a Q4 adjusted EPS of $11.86, surpassing estimates and showing a revenue increase of 1% to $3.43 billion. Dupixent sales, recorded by Sanofi (SNY), rose 31% to $3.22 billion. Regeneron's Eylea sales slightly declined, while Libtayo sales surged 44%. Additionally, Regeneron formed Regeneron Cell Medicines after acquiring assets from 2seventy bio Inc (TSVT), with REGN shares rising 3.26% in premarket trading.

Portfolio Pulse from Vandana Singh

February 02, 2024 | 4:08 pm

CHD

Church & Dwight Company, Inc. (NYSE:CHD) reported Q4 net sales of $1.528 billion, a 6.4% increase year over year, surpassing both its own and analyst expectations. Organic sales grew by 5.3%, driven by favorable price and product mix and higher volume. Adjusted EPS was $0.65, matching analyst consensus. The company saw growth in both domestic and international consumer sales but a decrease in Specialty Products' net sales. Gross margin improved due to pricing, volume, productivity, and the HERO acquisition. Church & Dwight raised its quarterly dividend by 4% and provided a positive outlook for 2024, expecting 4%-5% sales growth and 7%-9% adjusted EPS growth. Despite the positive report, CHD shares fell by 2.25% to $99.49.

Portfolio Pulse from Nabaparna Bhattacharya

February 02, 2024 | 4:02 pm

SYM

Symbotic (NASDAQ:SYM) is scheduled to release its quarterly earnings report on February 5, 2024, with an expected EPS of $-0.06. Analysts and investors are keen on not just the earnings beat but also the forward guidance. Historically, Symbotic's share price has reacted significantly to its earnings performance, with a notable 40.15% increase after last quarter's earnings beat. Over the past year, SYM shares have surged by 209.79%, indicating strong investor confidence. The upcoming earnings report is highly anticipated for its potential impact on stock performance.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 4:01 pm

KFRC

Kforce (NASDAQ:KFRC) is scheduled to release its quarterly earnings report on February 5, 2024, with an estimated EPS of $0.79. Historically, Kforce has shown mixed results in beating EPS estimates, with a notable 8.55% share price increase following last quarter's earnings beat. Over the past year, KFRC shares have risen by 18.77%, indicating a positive outlook among long-term investors. The upcoming earnings report and particularly the company's guidance for future quarters will be critical for investors.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 4:01 pm

IDXX

IDEXX Laboratories (NASDAQ:IDXX) is scheduled to release its quarterly earnings report on February 5, 2024, with analysts estimating an EPS of $2.11. Historical data shows that IDEXX's stock price reacts positively to earnings beats and guidance. Last quarter, IDEXX beat the EPS estimate by $0.16, leading to a 6.09% increase in its share price. Over the last year, IDXX shares have risen by 8.76%, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 4:01 pm

ACM

AECOM (NYSE:ACM) is scheduled to release its quarterly earnings report on February 5, 2024, with analysts expecting an EPS of $0.95. The company's past earnings performance shows a mix of beats and misses, with the last quarter beating estimates by $0.03 and resulting in a 7.37% share price increase the following day. AECOM's stock has seen a 1.36% increase over the last 52 weeks, trading at $89.73 as of February 1. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 4:01 pm